RVMD Dividend: Revolution Medicines Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

RVMD Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	11	35	29	42
Revenue Growth (YoY)	--	-100%	-69%	21%	-31%	-16%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	80	97	75	40	30	21
Research & Development	450	592	423	253	186	132
Operating Expenses	531	689	498	293	217	153
Other Non Operating Income (Expenses)	0	1	0	--	--	--
Pretax Income	-500	-600	-439	-249	-187	-108
Income Tax Expense	0	0	-3	0	0	0
Net Income	-499	-600	-436	-248	-187	-110
Net Income Growth	-12%	38%	76%	33%	70%	80%
Shares Outstanding (Diluted)	189.23	167.73	113.14	80.63	72.81	54.87
Shares Change (YoY)	13%	48%	40%	11%	33%	-7%
EPS (Diluted)	-2.64	-3.57	-3.85	-3.08	-2.57	-2.01
EPS Growth	-22%	-7%	25%	20%	28%	91%
Free Cash Flow	-777	-567	-358	-235	-153	-102
Free Cash Flow Per Share	-4.1	-3.38	-3.16	-2.91	-2.1	-1.85
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	-4,427.27%	-737.14%	-648.27%	-261.9%
Profit Margin	0%	0%	-3,963.63%	-708.57%	-644.82%	-261.9%
Free Cash Flow Margin	0%	0%	-3,254.54%	-671.42%	-527.58%	-242.85%
EBITDA	-526	-682	-481	-253	-184	-107
EBITDA Margin	0%	0%	-4,372.72%	-722.85%	-634.48%	-254.76%
D&A For EBITDA	5	7	6	5	4	3
EBIT	-531	-689	-487	-258	-188	-110
EBIT Margin	0%	0%	-4,427.27%	-737.14%	-648.27%	-261.9%
Effective Tax Rate	0%	0%	0.68%	0%	0%	0%